| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/04/2013 | EP2632951A2 Dkk1 antibodies and methods of use |
| 09/04/2013 | EP2632950A1 Method for preventing myocardial infarction-related complications |
| 09/04/2013 | EP2632949A1 Clostridium difficile-specific antibodies and uses thereof |
| 09/04/2013 | EP2632948A1 Spider silk fusion protein structures for binding to an organic target |
| 09/04/2013 | EP2632947A2 Non-antagonistic egfr-binding molecules and immunoconjugates thereof |
| 09/04/2013 | EP2632946A1 Method for the production of immunoglobulin single variable domains |
| 09/04/2013 | EP2632490A2 Novel egfr-binding molecules and immunoconjugates thereof |
| 09/04/2013 | EP2632489A2 Compositions targeting the soluble extracellular domain of e-cadherin and related methods for cancer therapy |
| 09/04/2013 | EP2527435A9 Methods and compositions for inactivating alpha 1,6 fucosyltransferase (FUT 8) gene expression |
| 09/04/2013 | CN1622995B Receptor nucleic acids and polypeptides |
| 09/04/2013 | CN103282495A Novel anti-dr5 antibody |
| 09/04/2013 | CN103282385A Fusion proteins for HIV therapy |
| 09/04/2013 | CN103282384A Combination pharmaceutical composition and methods of treating genitourinary system disorders |
| 09/04/2013 | CN103282383A Anti-cd38 antibodies |
| 09/04/2013 | CN103282382A 抗il-23抗体 Anti-il-23 antibody |
| 09/04/2013 | CN103282381A Improved anti-erum albumin binding variants |
| 09/04/2013 | CN103282380A Erythrocyte-binding therapeutics |
| 09/04/2013 | CN103282055A Anti-diabetic compounds |
| 09/04/2013 | CN103282050A Antitumor combinations containing antibodies recognizing specifically CD38 and bortezomib |
| 09/04/2013 | CN103276009A Construction and expression for campylobacter jejuni cytolethaldistending toxin expression vectors, and preparation for monoclonal antibody |
| 09/04/2013 | CN103275980A Antibodies, fusion protein and composition |
| 09/04/2013 | CN103275936A Brat-protein-resistant monoclonal antibody and application |
| 09/04/2013 | CN103275227A AXL antibodies |
| 09/04/2013 | CN103275226A Preparation, identification and application of monoclonal antibodies of specific anti-human EpCAMs (epithelial cell adhesion molecules) |
| 09/04/2013 | CN103275225A Anti-CD31/CD146 double-specific monoclonal antibody with high affinity and application thereof |
| 09/04/2013 | CN103275224A Fenneropenaeus chinensis beta-integrin VWA structural domain-resistant monoclonal antibody and preparation method thereof |
| 09/04/2013 | CN103275223A Method for preparing procalcitonin antibody |
| 09/04/2013 | CN103275222A Monoclonal antibody for blocking 12p40 function of interleukin as well as coding gene and application thereof |
| 09/04/2013 | CN103275221A Human antibodies that bind human tnf alpha |
| 09/04/2013 | CN103275220A The ED-A antigen of fibrinogen associated with the neovasculature of tumour metastases |
| 09/04/2013 | CN103275219A Schmallenberg virus nucleocapsid protein monoclonal antibody, and preparation method thereof |
| 09/04/2013 | CN103275218A Preparation method of freeze-dried egg yolk antibody |
| 09/04/2013 | CN103275217A Magnetic bead method for quickly purifying antibody |
| 09/04/2013 | CN103275216A Sequence based engineering and optimization of single chain antibodies |
| 09/04/2013 | CN103275212A Antihuman CD146 monoclone antibody, composition containing same, and method for testing dissolubility CD146 |
| 09/04/2013 | CN103275182A CD8+T cell dominant epitopes based on toxoplasmagondii bradyzoite antigens |
| 09/04/2013 | CN103272232A Preventive or remedy for inflammatory disease |
| 09/04/2013 | CN102796763B Preparation method and application of carp spermary bioreactor |
| 09/04/2013 | CN102757494B Preparation method of chicken egg yolk antibody against duck flavivirus |
| 09/04/2013 | CN102617734B Antibody Dab-2 against FGF-2 and application thereof |
| 09/04/2013 | CN101842388B Humanized antibodies against the beta-amyloyd peptide |
| 09/04/2013 | CN101687908B Antigen determinant of rheumatoid arthritis-specific autoantibody and use thereof |
| 09/04/2013 | CN101675077B Cross-species-specific bispecific binders |
| 09/04/2013 | CN101505794B scFV antibodies which pass epithelial and/or endothelial layers |
| 09/04/2013 | CN101415729B Antibodies against amyloid-beta peptide |
| 09/04/2013 | CN101269214B EG-VEGF nucleotide and using method |
| 09/03/2013 | US8524871 Modified gherlin peptides |
| 09/03/2013 | US8524869 Humanized antibodies against LIGHT and uses thereof |
| 09/03/2013 | US8524867 Optimized antibodies that target CD19 |
| 09/03/2013 | US8524866 Antibodies to the alpha-7 nicotinic receptors and methods of treating inflammatory disorders with the same |
| 09/03/2013 | US8524865 Antibodies and immunoconjugates and uses therefor |
| 09/03/2013 | US8524672 Method for inhibiting BAFF-R activity |
| 09/03/2013 | US8524667 Methods of treating gout using IL-1BETA antibodies |
| 09/03/2013 | US8524666 Methods of using vimentin to inhibit angiogenesis and endothelial cell proliferation |
| 09/03/2013 | US8524508 Methods of treating neuromyelitis optica (NMO) |
| 09/03/2013 | US8524460 PSCA: prostate stem cell antigen and uses thereof |
| 09/03/2013 | US8524251 Neisseria meningitidis antigens and compositions |
| 09/03/2013 | US8524236 Methods of antagonizing the binding of CD40 to CD40L with CD40L-specific monovalent polypeptides in autoimmune individuals |
| 09/03/2013 | US8524234 Antibody for selective inhibition of T-cell responses |
| 09/03/2013 | US8524232 Methods of treatment using taci-immunoglobulin fusion proteins |
| 09/03/2013 | US8524231 Antigen binding polypeptides |
| 09/03/2013 | US8524229 Medicament and a method for regulation of the vascular tone |
| 09/03/2013 | US8524228 Netrin-1 compositions and methods of use thereof |
| 09/03/2013 | US8524227 Anti-IL-TIF antibodies |
| 09/03/2013 | CA2586506C Immunoassays for topiramate |
| 09/03/2013 | CA2504963C Conjugates of tnf and a ligand of cd13 receptor in combination with interferon-gamma for treating cancer |
| 09/03/2013 | CA2464372C Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof |
| 09/03/2013 | CA2459827C Leafhopper ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 09/03/2013 | CA2459807C Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 09/03/2013 | CA2245877C Hybrid proteins which form heterodimers |
| 09/03/2013 | CA2241564C Wsx receptor and ligands |
| 08/29/2013 | WO2013126911A1 Inhibitors and agonists of the low density lipoprotein receptor related domain of lrp6 and/or lrp5 and uses thereof |
| 08/29/2013 | WO2013126904A1 Fraction i-iv-1 precipitation of immunoglobins from plasma |
| 08/29/2013 | WO2013126810A1 Anti sez6 antibodies and methods of use |
| 08/29/2013 | WO2013126746A2 Novel modulators and methods of use |
| 08/29/2013 | WO2013126740A1 Anti-big-endothelin-1 (big-et-1) antibodies and uses thereof |
| 08/29/2013 | WO2013126595A1 Methods for treating corneal and conjunctival inflammation and inflammatory disorders |
| 08/29/2013 | WO2013125879A1 Antibody to d-alanine-d-alanine ligase and detection of antibiotic-resistant bacteria using same |
| 08/29/2013 | WO2013124462A1 Means and methods of measuring parathyroid hormone in patients suffering from oxidative stress |
| 08/29/2013 | WO2013124451A1 Sequence symmetric modified igg4 bispecific antibodies |
| 08/29/2013 | WO2013124450A1 Sequence symmetric modified igg4 bispecific antibodies |
| 08/29/2013 | WO2013124419A1 Her3 inhibitor for modulating radiosensitivity |
| 08/29/2013 | WO2013124327A1 Tim receptors as virus entry cofactors |
| 08/29/2013 | WO2013124324A1 Tam receptors as virus entry cofactors |
| 08/29/2013 | WO2013124297A1 Combination of hb-egf binding protein and egfr inhibitor |
| 08/29/2013 | WO2013123591A1 Multimerized single domain antibody ligands of prothrombin as inhibitors of blood and extravascular coagulation |
| 08/29/2013 | WO2013104918A3 Binding molecule |
| 08/29/2013 | WO2013102659A3 Binding agents to intracellular target molecules |
| 08/29/2013 | WO2013095091A3 Rsv g protein specific antibodies |
| 08/29/2013 | WO2013092952A3 Method for selectively quantifying a-beta aggregates |
| 08/29/2013 | WO2013087785A3 Bowman-birk protease inhibitor (bbi) binding peptides, and uses thereof in the separation, detection or purification of bbi |
| 08/29/2013 | WO2013037484A3 Anti-aplhabetatcr antibody |
| 08/29/2013 | WO2013036101A9 Rubber allergenic proteins and immunoassay derived thereof |
| 08/29/2013 | US20130227747 Chitinous polysaccharide antigen-binding proteins |
| 08/29/2013 | US20130225796 Protein purification method |
| 08/29/2013 | US20130225668 Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer |
| 08/29/2013 | US20130225490 Antibodies That Inhibit TSLP Activity |
| 08/29/2013 | US20130225443 Method of examining polycystic kidney disease and method of screening for therapeutic agent of the disease |
| 08/29/2013 | US20130225403 Compositions for seed treatment |
| 08/29/2013 | US20130224880 Reagents and methods for detecting protein crotonylation |